Black Patients Less Likely to Receive Targeted Radiation
Study finds racial disparities in the use of proton beam therapy, a focused treatment that can reduce side effects.
Progress Against Cancer
Study finds racial disparities in the use of proton beam therapy, a focused treatment that can reduce side effects.
New studies probe how to match targeted therapies to children with cancer.
A magnet-guided robot could help doctors look for signs of cancer deeper in the passages of the lungs.
Study shows women have a higher risk of side effects from immunotherapy, adding to evidence that men and women react differently to treatment.
Genetic tests create opportunities but also confusion for breast cancer patients, and more from the week in cancer news.
Cognitive effects from COVID-19 and cancer treatment look very similar. Collaboration may lead to better treatment for both.
Cancer cells exploit an aging “infrastructure” to threaten life in those 60 and older.
The FDA granted accelerated approval to selpercatinib to treat solid tumors harboring RET gene fusions. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to selpercatinib (Retevmo) for the treatment of adult...
The FDA granted full approval to selpercatinib for the treatment of patients with advanced lung cancer. The U.S. Food and Drug Administration (FDA) has approved selpercatinib (Retevmo) for the treatment of patients with locally...
Researchers highlight need for outreach and educational programs to address survivorship disparities.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now